Baculovirus Expression Vector System for Gene Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing baculovirus expression vector systems for gene therapy are time-consuming and costly due to the generation of multiple baculovirus expression vectors, which drives up production costs and inefficiencies.
Innovation Solution
A recombinant bacmid system with two or more foreign sequence insertion sites and donor vectors capable of mediating foreign sequence insertion, utilizing a baculovirus shuttle vector and stable cell lines to streamline the production process, including a bacterial replicon, selectable markers, reporter genes, and site-specific recombination events.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If multiple baculovirus expression vectors are used to produce gene therapy vectors, then the production capability is improved, but the time consumption and production cost increase
Solution Approach 1:
The patent combines multiple foreign sequences into a single baculovirus expression vector by utilizing multiple foreign sequence insertion sites within one vector construct. This merging approach allows co-expression of multiple proteins from different foreign sequences in a single vector, eliminating the need to generate and manage multiple separate vectors, thereby reducing time consumption while maintaining production capability.
Solution Approach 2:
The baculovirus expression vector is designed with multi-functionality by incorporating multiple foreign sequence insertion sites that can accommodate different heterologous genes. This universal vector can express multiple different proteins simultaneously, replacing the need for multiple specialized vectors and reducing both time and cost overhead associated with vector generation and management.
2Productivity
If multiple baculovirus expression vectors are generated for producing gene therapy vectors, then the production capability is improved, but the production cost increases
Solution Approach 1:
The patent merges multiple foreign sequences into a single vector construct, reducing the number of vectors that need to be generated, characterized, and manufactured. This consolidation directly reduces production costs associated with vector development while maintaining the ability to produce multiple gene therapy vectors through a single parental vector.
Solution Approach 2:
The universal baculovirus expression vector with multiple insertion sites serves multiple functions simultaneously, allowing the generation of various gene therapy vectors from a single platform. This multi-functionality reduces the overall cost of vector production by eliminating the need to develop and maintain multiple separate vector systems.
3Loss of time
If a single baculovirus expression vector with multiple foreign sequence insertion sites is used, then the time consumption and production cost are reduced, but the device complexity increases
Solution Approach 1:
The vector is segmented into distinct functional modules including multiple foreign sequence insertion sites, each with specific characteristics. This segmentation allows for systematic organization of complexity, making the vector easier to manipulate and understand despite containing multiple insertion sites. Each insertion site can be independently targeted and modified.
Solution Approach 2:
The patent employs intermediary elements such as linkers and specific structural components between foreign sequence insertion sites that facilitate modular assembly and simplify the overall vector architecture. These intermediary elements help manage the complexity by providing standardized interfaces and reducing the need for custom design for each insertion site.
Data Source
AI summary
Provided herein is a baculovirus expression vector system for the production of a desired protein. In one aspect, the desired protein is a closed-ended DNA (ceDNA) molecule comprising wild-type and/or truncated inverted terminal repeats derived from a genome of a member of the viral family Parvoviridae.